Nanjing Pharmaceutical Group Company Limited (SHA:600713)
5.43
+0.02 (0.37%)
Feb 3, 2026, 3:00 PM CST
Nanjing Pharmaceutical Group Company Company Description
Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China.
It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business.
The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025.
Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.
Nanjing Pharmaceutical Group Company Limited
| Country | China |
| Founded | 1951 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 4,830 |
| CEO | Liang Zhang |
Contact Details
Address: Building 2 Nanjing, 210012 China | |
| Phone | 86 25 8455 2601 |
| Website | njyy.com |
Stock Details
| Ticker Symbol | 600713 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000KV1 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Liang Zhang | President and Director |
| Jian Sun CPA | Chief Accountant and Financial Director |
| Qing Yang | Chief Auditor and Supervisor |
| Xun Jie Luo | Vice President and Director |
| Wen Jun Li | Vice President and Secretary of the Board of Directors |
| Jian Zhong Tang | Vice President |
| Chuang Feng | Vice President |
| Hong Xiao | Vice President |
| Yuping Peng | Vice President |
| Xia Yao | Employee Supervisor and Vice President |